Work Detail
Retinol Acetate + Associations - Active Principle (1): Retinol Acetate + Aminoacids; Active Principle (2): Methionine + Chloramphenicol; Concentration, Acetylcysteine - Active Principle: Acetylcysteine; Concentration/Dosage: 20 Mg/G; Pharmaceutical Form: Granulated; Presentation: Envelope 5 G; Component, Acetylcysteine - Active Principle: Acetylcysteine; Concentration/Dosage: 600 Mg; Pharmaceutical Form: Effervescent Tablet; Presentation: .; Componis, Pamidronic Acid - Active Principle: Pamidronic Acid; Concentration/Dosage: 90 Mg; Pharmaceutical Form: Po Lyophilized For Injectable Solution; Present, Albendazol - Active Principle: Albendazol; Concentration/Dosage: 40 Mg/Ml; Pharmaceutical Form: Oral Suspension; Presentation: 10Ml Bottle; Component:., 02/18/2025, Alendronato De Sodio - Active Principle: Alendronato De Sodio; Concentration/Dosage: 70 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component, Amitriptyline Active Principle: Amitriptyline, Hydrochloride; Concentration/Dosage: 75 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .; Anlodipino - Active Principle: Anlodipino, Besylate; Concentration/Dosage: 10 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .; Calcica Arguvastatin - Active Principle: Calcica Adoorvastatin; Concentration/Dosage: 80 Mg; Pharmaceutical Form: Coated Tablet; Presentation:., Atropin - Active Principle: Atropin, Sulfate; Concentration/Dosage: 0, 5 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: Ampoule 1 Ml; Comp, Benzilpenyicillin Benzatin - Active Principle: Benzilpenyicillin Benzatin; Concentration/Dosage: 600,000 Iu; Pharmaceutical Form: Po For Inje Suspension, Bisacodil - Active Principle: Bisacodil; Concentration/Dosage: 5 Mg; Pharmaceutical Form: Dragea; Presentation: .; Component: .; Bosentana - Active Principle: Bosentana; Concentration/Dosage: 62, 5 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .; Brigatinib - Active Principle: Brigatinib; Concentration/Dosage: 90 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Budesonide + Associations - Active Principle: Budesonide + Formoterol Fumarate; Concentration/Dosage: 100 Mcg + 6 Mcg; Pharmaceutical Form: Suspension, Budsonide + Associations - Active Principle: Budesonide + Formoterol Fumarate; Concentration/Dosage: 200 Mcg + 6 Mcg; Pharmaceutical Form: Po Inalant, Budesonide + Associations - Active Principle: Budesonide + Formoterol Fumarate; Concentration/Dosage: 400 Mcg + 12 Mcg; Pharmaceutical Form: Po Inalan, Scopolamine Butylbromide - Active Principle: Scopolamine Butylbromide; Concentration/Dosage: 10 Mg/Ml; Pharmaceutical Form: Oral Solution; Present, Carbonatin - Active Principle: Carboplatin; Concentration/Dosage: 150 Mg; Pharmaceutical Form: Injectable Solution; Presentation: Flascopela; Compon, Carboplatin - Active Principle: Carbolatin; Concentration/Dosage: 450 Mg; Pharmaceutical Form: Injectable Solution; Presentation: Flascopela; Compon, Cyclosporine - Active Principle: Cyclosporine For Micro -Esual; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Soft Gelatinous Capsule; Presentation, Cyclosporine - Active Principle: Cyclosporine For Micro -Commits; Concentration/Dosage: 25 Mg; Pharmaceutical Form: Soft Gelatinous Capsule; Presentation, Cyclosporine - Active Principle: Cyclosporine For Micro -Commits; Concentration/Dosage: 50 Mg; Pharmaceutical Form: Soft Gelatinous Capsule; Presentation, Cyclosporine - Active Principle
View Notice Now...
Fill Detail for Getting Instant Access
Instant Access